Pharmacotherapeutics and Why TB Presents Differently in HIV
![Pharmacotherapeutics and Why TB Presents Differently in HIV](/sites/default/files/styles/thumbnail/public/images/publications/sntc_0.jpg?itok=cxawUe2U)
Drs. Jacques Grosset and Timothy Sterling will discuss the rationale for and potential new approaches to treatment of TB in HIV-infected individuals. Primary and secondary resistance of TB medications and the role of therapeutic drug monitoring for HIV-infected patients will be explored. The...